These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 6760217)

  • 1. [Clinical double blind comparison of diclofensine and placebo in geriatric patients with depressive syndromes].
    Jansen W; Brückner GW; Henauer S; Omer LM
    Pharmacopsychiatria; 1982 Nov; 15(6):205-9. PubMed ID: 6760217
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic efficacy and tolerance of diclofensine in psychoreactive depression--a double-blind comparison with placebo.
    Omer OL; Díaz-Olivera M; Ismail S
    Methods Find Exp Clin Pharmacol; 1984 Mar; 6(3):147-51. PubMed ID: 6379345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Desvenlafaxine 50 and 100 mg/d in the treatment of major depressive disorder: an 8-week, phase III, multicenter, randomized, double-blind, placebo-controlled, parallel-group trial and a post hoc pooled analysis of three studies.
    Tourian KA; Padmanabhan SK; Groark J; Brisard C; Farrington D
    Clin Ther; 2009 Jun; 31 Pt 1():1405-23. PubMed ID: 19698901
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind comparison of diclofensine with nomifensine in outpatients with dysphoric mood.
    Funke HJ; Holtmann W; Ismail S; Jansen W; Leonhardt KF; Muth H; Omer LM; O'Connolly M; Ramm H
    Pharmacopsychiatry; 1986 May; 19(3):120-3. PubMed ID: 3725890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A double-blind comparative evaluation of the efficacy and safety of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Merideth CH; Feighner JP; Hendrickson G
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):73-7. PubMed ID: 6370981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomifensine in geriatric inpatients: a placebo-controlled study.
    Jansen W; Siegfried K
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):63-7. PubMed ID: 6370979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors that influence the outcome of placebo-controlled antidepressant clinical trials.
    Niklson IA; Reimitz PE; Sennef C
    Psychopharmacol Bull; 1997; 33(1):41-51. PubMed ID: 9133750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A two-center double-blind study of nomifensine, imipramine, and placebo in depressed geriatric outpatients.
    Cohn JB; Varga L; Lyford A
    J Clin Psychiatry; 1984 Apr; 45(4 Pt 2):68-72. PubMed ID: 6370980
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Milnacipran and pindolol: a randomized trial of reduction of antidepressant latency.
    Isaac MT; Isaac MB; Gallo F; Tournoux A
    Hum Psychopharmacol; 2003 Dec; 18(8):595-601. PubMed ID: 14696018
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diclofensine and imipramine. A double-blind comparative trial in depressive out-patients.
    Capponi R; Hormazabal L; Schmid-Burgk W
    Neuropsychobiology; 1985; 14(4):173-80. PubMed ID: 3915058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind, placebo-controlled trial of two dose ranges of nefazodone in the treatment of depressed outpatients.
    Mendels J; Reimherr F; Marcus RN; Roberts DL; Francis RJ; Anton SF
    J Clin Psychiatry; 1995; 56 Suppl 6():30-6. PubMed ID: 7649971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled trial of fluvoxamine versus imipramine in outpatients with major depression.
    March JS; Kobak KA; Jefferson JW; Mazza J; Greist JH
    J Clin Psychiatry; 1990 May; 51(5):200-2. PubMed ID: 2110560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Duloxetine versus escitalopram and placebo: an 8-month, double-blind trial in patients with major depressive disorder.
    Pigott TA; Prakash A; Arnold LM; Aaronson ST; Mallinckrodt CH; Wohlreich MM
    Curr Med Res Opin; 2007 Jun; 23(6):1303-18. PubMed ID: 17559729
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gepirone extended-release treatment of anxious depression: evidence from a retrospective subgroup analysis in patients with major depressive disorder.
    Alpert JE; Franznick DA; Hollander SB; Fava M
    J Clin Psychiatry; 2004 Aug; 65(8):1069-75. PubMed ID: 15323591
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety.
    Fawcett J; Barkin RL
    J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.
    Jahn H; Schick M; Kiefer F; Kellner M; Yassouridis A; Wiedemann K
    Arch Gen Psychiatry; 2004 Dec; 61(12):1235-44. PubMed ID: 15583115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind comparison of Org 3770, amitriptyline, and placebo in major depression.
    Bremner JD
    J Clin Psychiatry; 1995 Nov; 56(11):519-25. PubMed ID: 7592505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pilot trials with diclofensine, a new psychoactive drug in depressed patients.
    Omer LM
    Int J Clin Pharmacol Ther Toxicol; 1982 Jul; 20(7):320-6. PubMed ID: 7107085
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Review of placebo-controlled trials with bupropion.
    Zung WW
    J Clin Psychiatry; 1983 May; 44(5 Pt 2):104-14. PubMed ID: 6406436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies.
    Brannan SK; Mallinckrodt CH; Detke MJ; Watkin JG; Tollefson GD
    J Psychiatr Res; 2005 Mar; 39(2):161-72. PubMed ID: 15589564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.